Iniobong Ekong | Vaccine | Research Excellence Award

Dr. Iniobong Ekong | Vaccine | Research Excellence Award

Ministry of Health | Sierra Leone

Dr. Iniobong Ekong is a public health researcher affiliated with the Federal Capital Territory Health & Human Services Secretariat, Abuja, Nigeria, with expertise in women’s health, non-communicable diseases, and health systems research in low- and middle-income settings. He has authored 6 peer-reviewed publications indexed in Scopus, attracting 190 citations and achieving an h-index of 3, reflecting the growing influence of his work. His research emphasizes participatory and community-based approaches, notably employing Photovoice methodology to amplify the lived experiences of women of reproductive age facing health inequities. Dr. Ekong has collaborated extensively, working with over 170 co-authors across multidisciplinary and international teams, strengthening evidence generation and policy relevance. His scholarship contributes to improved understanding of structural and social barriers to healthcare access, supporting more inclusive public health interventions and informing decision-making to advance equitable health outcomes in Nigeria and comparable global contexts.

Citation Metrics (Scopus)
190
150
100
50
0
Citations

190

Documents

6

h-index

3

Citations

Documents

h-index

View Scopus Profile

Top 5 Featured Publications

Noemí Sevilla | Vaccine Research | Excellence in Research Award

Prof. Dr. Noemí Sevilla | Vaccine Research | Excellence in Research Award 

Professor | Centro de Investigación en Sanidad Animal (CISA)-CSIC | Spain

Prof. Dr. Noemí Sevilla Hidalgo is a distinguished Full Professor and Director at the Centro de Investigación en Sanidad Animal (CISA-INIA, CSIC, Spain), with a prolific career spanning over three decades in virology, immunology, and animal health, focusing on zoonotic and veterinary pathogens. Her research has elucidated viral immune evasion strategies, host-pathogen interactions, and immune responses in both small and large animal models, directly informing vaccine design. After completing her PhD in Molecular Biology at Universidad Autónoma de Madrid, where she received the Doctorate Extraordinary Award, she pursued postdoctoral training at The Scripps Research Institute (TSRI, USA) under a Human Frontiers Fellowship, studying dendritic cell roles in viral immunity and demonstrating dual viral evasion mechanisms. These results were published in high-impact journals and have received over 3,115 citations. Returning to Spain via the Ramon y Cajal program, she established her research group at CISA, focusing on Bluetongue virus (BTV), Peste des Petits Ruminants virus (PPRV), and more recently, SARS-CoV-2 and Crimean-Congo hemorrhagic fever virus. Her contributions span viral immune evasion, characterization of host immune responses to BTV and PPRV, and the development of recombinant adenoviral vaccine platforms. Sevilla has actively contributed to scientific leadership through conference organization, editorial service, and grant review panels. She has received eight competitive fellowships and authored 70 publications, maintaining an h-index of 30 with 3,115 citations, reflecting her global impact and sustained contributions to virology, immunology, and vaccine research.

Profiles: Scopus | ORCID

Featured Publications

1. Louloudes-Lázaro, A., Nogales-Altozano, P., Rojas, J. M., Veloz, J., Carlón, A. B., Van Rijn, P. A., Martín, V., Fernández-Sesma, A., & Sevilla, N. (2025). Double-stranded RNA orbivirus disrupts the DNA-sensing cGAS-sting axis to prevent type I IFN induction. Cellular and Molecular Life Sciences.

2. Herder, V., Caporale, M., MacLean, O. A., Pintus, D., Huang, X., Nomikou, K., Palmalux, N., Nichols, J., Scivoli, R., Boutell, C., … (2024). Correlates of disease severity in bluetongue as a model of acute arbovirus infection. PLoS Pathogens.

3. Ciudad, C. J., Valiuska, S., Rojas, J. M., Nogales-Altozano, P., Aviñó, A., Eritja, R., Chillón, M., Sevilla, N., & Noé, V. (2024). Polypurine reverse hoogsteen hairpins as a therapeutic tool for SARS-CoV-2 infection. Journal of Biological Chemistry. Cited by: 4

4. Herder, V., Caporale, M., MacLean, O. A., Pintus, D., Huang, X., Nomikou, K., Palmalux, N., Nichols, J., Scivoli, R., Boutell, C., … (2024). A machine learning framework to identify the correlates of disease severity in acute arbovirus infection [Preprint]. bioRxiv.Cited by: 4

5. Pinsino, A., & Sevilla, N. (2024). Editorial: Women in comparative immunology. Frontiers in Immunology.Cited by: 5